Date until the warrants or rights are exercisable, in CCYY-MM-DD format.

No definition available.

Name:	syn_ClassOfWarrantOrRightDateToWhichWarrantsOrRightsExercisable
Namespace Prefix:	syn_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Period the warrants or rights are exercisable.

+ References

No definition available.

+ Details

Name:	syn_ClassOfWarrantOrRightExercisablePeriod
Namespace Prefix:	syn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The additional number of common stock to be held by the related party under stock purchase agreement.

+ References

No definition available.

+ Details

Name:	syn_NumberOfCommonStockToBeHeldByRelatedParty
Namespace Prefix:	syn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of common stock to be issued under stock purchase agreement.

+ References

No definition available.

+ Details

Name:	syn_NumberOfCommonStockToBeIssued
Namespace Prefix:	syn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount represents the value of milestones payments related to license agreement.

+ References

No definition available.

+ Details

Name:	syn_RevenueRecogntionMilestoneMethodPayments
Namespace Prefix:	syn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

+ Details

Name:	us-gaap_CommonStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

+ Details

Name:	us-gaap_CommonStockValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_OwnershipAxis=syn_SyntheticBiomicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=syn_SeriesWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=syn_SeriesBWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=syn_ScottTarriffMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=syn_CedarssinaiMedicalCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=syn_CedarssinaiMedicalCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Related Party Transactions (Details) - USD ($)	1 Months Ended	12 Months Ended
Related Party Transactions (Details) - USD ($)	Nov. 18, 2016	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Oct. 31, 2018	Oct. 10, 2018	Sep. 05, 2018
Related Party Transaction [Line Items]
Common Stock, Shares, Issued			16,808,758	15,484,411
Common Stock, Value, Issued			$ 17,000	$ 15,000
Common Stock, Par or Stated Value Per Share			$ (0.001)	$ (0.001)
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						13,672,173
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 1.38	$ 1.38
Synthetic Biomics Inc [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners							17.00%
Series A Warrant [Member]
Related Party Transaction [Line Items]
Class of Warrant or Right, Exercisable period	4 years
Series B Warrant [Member]
Related Party Transaction [Line Items]
Proceeds from Issuance of Common Stock	$ 8,572
Scott Tarriff [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, Issued for Services	8,572
Scott Tarriff [Member] \| Series A Warrant [Member]
Related Party Transaction [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	8,572
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 50.05
Scott Tarriff [Member] \| Series B Warrant [Member]
Related Party Transaction [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	8,572
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 60.20
Class of Warrant or Right, Date to which Warrants or Rights Exercisable	Dec. 31, 2017
Cedarssinai Medical Center [Member]
Related Party Transaction [Line Items]
Number Of Common Stock To Be Issued							50,000
Revenue recogntion milestone method payments		$ 350,000
Cedarssinai Medical Center [Member] \| Synthetic Biomics Inc [Member]
Related Party Transaction [Line Items]
Number Of Common Stock To Be Held By Related Party							7,480,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners							17.00%
Cedarssinai Medical Center [Member] \| Cedarssinai Medical Center [Member]
Related Party Transaction [Line Items]
Number Of Common Stock To Be Issued							(50,000)
Cedarssinai Medical Center [Member] \| Cedarssinai Medical Center [Member] \| Synthetic Biomics Inc [Member]
Related Party Transaction [Line Items]
Number Of Common Stock To Be Held By Related Party							7,480,000